30 Min ACTH stimulation test as predictor of hypothalamic-pituitary-adrenocortical function. Comparison with metyrapone test
- PMID: 6245561
- DOI: 10.1111/j.0954-6820.1980.tb09687.x
30 Min ACTH stimulation test as predictor of hypothalamic-pituitary-adrenocortical function. Comparison with metyrapone test
Abstract
In 32 subjects the hypothalamic-pituitary-adrenocortical (HPA) response to metyrapone was found to correlate significantly with the adrenocortical response to exogenous ACTH. This report provides additional evidence suggesting that a 30 min exogenous ACTH stimulation test accurately predicts the integrated responsiveness of the HPA system to various stimuli.
Similar articles
-
The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.Clin Endocrinol (Oxf). 1994 May;40(5):603-9. doi: 10.1111/j.1365-2265.1994.tb03011.x. Clin Endocrinol (Oxf). 1994. PMID: 8013141
-
Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome.J Endocrinol Invest. 2004 Jan;27(1):42-6. doi: 10.1007/BF03350909. J Endocrinol Invest. 2004. PMID: 15053242 Clinical Trial.
-
Metyrapone test for hypothalamic-pituitary-adrenocortical function.Clin Endocrinol (Oxf). 1994 Nov;41(5):695-6. doi: 10.1111/j.1365-2265.1994.tb01840.x. Clin Endocrinol (Oxf). 1994. PMID: 7828362 No abstract available.
-
The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts?J Endocrinol Invest. 2003;26(7 Suppl):25-30. J Endocrinol Invest. 2003. PMID: 14604063 Review.
-
Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.Endocr Rev. 1984 Summer;5(3):371-94. doi: 10.1210/edrv-5-3-371. Endocr Rev. 1984. PMID: 6088218 Review.
Cited by
-
A comparison between short synacthen test and depot synacthen test in the evaluation of cortisol reserve of adrenal gland in normal subjects.J Endocrinol Invest. 1995 Dec;18(11):823-6. doi: 10.1007/BF03349827. J Endocrinol Invest. 1995. PMID: 8778152 Clinical Trial.
-
Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients.Cancer Chemother Pharmacol. 1985;15(2):167-70. doi: 10.1007/BF00257530. Cancer Chemother Pharmacol. 1985. PMID: 3160504
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources